BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients

2789

A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to their multidisciplinary team meetings from the first-time presentation of BASIL-2 led chief investigator Andrew Bradbury (University of Birmingham, Birmingham, UK) to deliver the stark message: a patient who needs a below-the-knee revascularisation with or without a femoropopliteal revascularisation is likely to do better if they are treated with a best endovascular-first strategy rather than a vein bypass-first approach.

Click here to read our full coverage of the BASIL-2 results.


LEAVE A REPLY

Please enter your comment!
Please enter your name here